These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34252514)

  • 21. Probing the mechanism of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III mtFabH: factors influencing catalysis and substrate specificity.
    Brown AK; Sridharan S; Kremer L; Lindenberg S; Dover LG; Sacchettini JC; Besra GS
    J Biol Chem; 2005 Sep; 280(37):32539-47. PubMed ID: 16040614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Acyl-AcpM-Binding Protein Confers Intrinsic Sensitivity to Fatty Acid Synthase Type II Inhibitors in
    Li M; Huang Q; Zhang W; Cao Y; Wang Z; Zhao Z; Zhang X; Zhang J
    Front Microbiol; 2022; 13():846722. PubMed ID: 35444621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the essential FAS II β-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii.
    Belardinelli JM; Morbidoni HR
    Mol Microbiol; 2012 Nov; 86(3):568-79. PubMed ID: 22994892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substrate recognition by β-ketoacyl-ACP synthases.
    Borgaro JG; Chang A; Machutta CA; Zhang X; Tonge PJ
    Biochemistry; 2011 Dec; 50(49):10678-86. PubMed ID: 22017312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisiting the assignment of Rv0241c to fatty acid synthase type II of Mycobacterium tuberculosis.
    Sacco E; Slama N; Bäckbro K; Parish T; Laval F; Daffé M; Eynard N; Quémard A
    J Bacteriol; 2010 Aug; 192(15):4037-44. PubMed ID: 20511508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological function of mycobacterial mtFabD, an essential malonyl-CoA:AcpM transacylase of type 2 fatty acid synthase FASII, in yeast mct1Delta cells.
    Gurvitz A
    Comp Funct Genomics; 2009; 2009():836172. PubMed ID: 19859569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trapping the dynamic acyl carrier protein in fatty acid biosynthesis.
    Nguyen C; Haushalter RW; Lee DJ; Markwick PR; Bruegger J; Caldara-Festin G; Finzel K; Jackson DR; Ishikawa F; O'Dowd B; McCammon JA; Opella SJ; Tsai SC; Burkart MD
    Nature; 2014 Jan; 505(7483):427-31. PubMed ID: 24362570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A back-door Phenylalanine coordinates the stepwise hexameric loading of acyl carrier protein by the fatty acid biosynthesis enzyme β-hydroxyacyl-acyl carrier protein dehydratase (FabZ).
    Shen S; Hang X; Zhuang J; Zhang L; Bi H; Zhang L
    Int J Biol Macromol; 2019 May; 128():5-11. PubMed ID: 30677439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of Specificity of Phenotypic Screens for Inhibitors of the Mycobacterium tuberculosis FAS-II System.
    Grzegorzewicz AE; Lelièvre J; Esquivias J; Angala B; Liu J; Lee RE; McNeil MR; Jackson M
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.
    Grzegorzewicz AE; Korduláková J; Jones V; Born SE; Belardinelli JM; Vaquié A; Gundi VA; Madacki J; Slama N; Laval F; Vaubourgeix J; Crew RM; Gicquel B; Daffé M; Morbidoni HR; Brennan PJ; Quémard A; McNeil MR; Jackson M
    J Biol Chem; 2012 Nov; 287(46):38434-41. PubMed ID: 23002234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.
    Veyron-Churlet R; Molle V; Taylor RC; Brown AK; Besra GS; Zanella-Cléon I; Fütterer K; Kremer L
    J Biol Chem; 2009 Mar; 284(10):6414-24. PubMed ID: 19074144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, antitubercular activity and mechanism of resistance of highly effective thiacetazone analogues.
    Coxon GD; Craig D; Corrales RM; Vialla E; Gannoun-Zaki L; Kremer L
    PLoS One; 2013; 8(1):e53162. PubMed ID: 23301038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point mutations within the fatty acid synthase type II dehydratase components HadA or HadC contribute to isoxyl resistance in Mycobacterium tuberculosis.
    Gannoun-Zaki L; Alibaud L; Kremer L
    Antimicrob Agents Chemother; 2013 Jan; 57(1):629-32. PubMed ID: 23114755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification, characterization, and inhibition of Plasmodium falciparum beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ).
    Sharma SK; Kapoor M; Ramya TN; Kumar S; Kumar G; Modak R; Sharma S; Surolia N; Surolia A
    J Biol Chem; 2003 Nov; 278(46):45661-71. PubMed ID: 12930838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new dehydratase conferring innate resistance to thiacetazone and intra-amoebal survival of Mycobacterium smegmatis.
    Carrère-Kremer S; Blaise M; Singh VK; Alibaud L; Tuaillon E; Halloum I; van de Weerd R; Guérardel Y; Drancourt M; Takiff H; Geurtsen J; Kremer L
    Mol Microbiol; 2015 Jun; 96(5):1085-102. PubMed ID: 25754266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and structural analysis of aromatic inhibitors of type II dehydroquinase from Mycobacterium tuberculosis.
    Howard NI; Dias MV; Peyrot F; Chen L; Schmidt MF; Blundell TL; Abell C
    ChemMedChem; 2015 Jan; 10(1):116-33. PubMed ID: 25234229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Hydroxyacyl-acyl Carrier Protein Dehydratase (FabZ) from Francisella tularensis and Yersinia pestis: Structure Determination, Enzymatic Characterization, and Cross-Inhibition Studies.
    McGillick BE; Kumaran D; Vieni C; Swaminathan S
    Biochemistry; 2016 Feb; 55(7):1091-9. PubMed ID: 26818694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of a novel dehydratase of the fatty acid synthase type II critical for ketomycolic acid biosynthesis and virulence of Mycobacterium tuberculosis.
    Lefebvre C; Frigui W; Slama N; Lauzeral-Vizcaino F; Constant P; Lemassu A; Parish T; Eynard N; Daffé M; Brosch R; Quémard A
    Sci Rep; 2020 Feb; 10(1):2112. PubMed ID: 32034201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycobacterium tuberculosis acyl carrier protein inhibits macrophage apoptotic death by modulating the reactive oxygen species/c-Jun N-terminal kinase pathway.
    Paik S; Choi S; Lee KI; Back YW; Son YJ; Jo EK; Kim HJ
    Microbes Infect; 2019; 21(1):40-49. PubMed ID: 29981934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis.
    Lee YR; Hwang JK; Lee HS; Cheon YJ; Ryu JH; Lee SI; Kwak HB; Lee SM; Kim JS; Park JW; Jeon R; Park BH
    Br J Pharmacol; 2011 Sep; 164(2b):794-806. PubMed ID: 21501144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.